Vol. 45 No. 8 (2006): Acta Oncologica

Articles

• Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH)

  Steen J. Bonnema, Viveque E. Nielsen, Laszlo Hegedüs

  1051-1058

  Published: 2006-01-01

  • PDF

• “Distributed proton radiation therapy”-A new concept for advanced competence support

  Mikael Karlsson, Thomas Björk-Eriksson, Olof Mattsson, Sören Mattsson, Anders Montelius, Per Nilsson, Björn Zackrisson

  1094-1101

  Published: 2006-01-01

  • PDF

• Sequential evaluation of hepatic functional reserve by 99mTechnetium-galactosyl human serum albumin scinitigraphy after proton beam therapy: a report of three cases and a review of the literatures

  Hiroshi Igaki, Koichi Tokuuye, Tohoru Takeda, Shinji Sugahara, Masaharu Hata, Takayuki Hashimoto, Nobuyoshi Fukumitsu, Jin Wu, Kayoko Ohnishi, Kiyoshi Ohara, Yasuyuki Akine

  1102-1107

  Published: 2006-01-01

  • PDF

• Effect of timing of surgery on survival after preoperative hyperfractionated accelerated radiotherapy (HART) for locally advanced rectal cancer (LARC): Is it a matter of days?

  Philippe A. Coucke, Markus Notter, Maurice Matter, Fabrizio Fasolini, Jean-Marie Calmes, Rolph Schlumpf, Norbert Schwegler, Bernhard Stamm, Hu Phuoc Do, Hanifa Bouzourene

  1086-1093

  Published: 2006-01-01

  • PDF

• Short course continuous, hyperfractionated, accelerated radiation therapy (CHART) as preoperative treatment for rectal cancer

  S. Brooks, R. Glynne–Jones, R. Novell, M. Harrison, K. Brown, A. Makris

  1079-1085

  Published: 2006-01-01

  • PDF

• Glucocorticoid receptor subunit gene expression in thyroid gland and adenomas

  Xiao-Wen Zhang, Yuan Li, Zhen-Lin Wang, Peng Li

  1073-1078

  Published: 2006-01-01

  • PDF

• Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors

  Sang Min Yoon, Eun Kyung Choi, Sang-Wook Lee, Byong Yong Yi, Seung Do Ahn, Seong Soo Shin, Heon Joo Park, Su Ssan Kim, Jin-Hong Park, Si Yeol Song, Charn Il Park, Jong Hoon Kim

  1108-1114

  Published: 2006-01-01

  • PDF

• A prospective clinical trial to assess the efficacy of radioiodine ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer undergoing sub-total thyroidectomy

  C. S. Bal, Ajay Kumar, Prem Chandra, S. N. Dwivedi, G. S. Pant

  1067-1072

  Published: 2006-01-01

  • PDF

• Functioning thyroid carcinomas-some historical aspects

  Lars-Gunnar Larsson

  1062-1066

  Published: 2006-01-01

  • PDF

• Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer

  Min Li, Yan-Fang Zhu, Yong-Lin Chen, Bang-Zhi Zhang, Rui Wang

  1115-1119

  Published: 2006-01-01

  • PDF

• Treatment results of radiotherapy for carcinoma of the cervical esophagus

  Kazunari Yamada, Masao Murakami, Yoshiaki Okamoto, Yoshishige Okuno, Toshifumi Nakajima, Fusako Kusumi, Hiroshi Takakuwa, Satoru Matsusue

  1120-1125

  Published: 2006-01-01

  • PDF

• Risk of parathyroid adenomas in patients with thyrotoxicosis exposed to radioactive iodine

  Torgny Rasmuson, Björn Tavelin

  1059-1061

  Published: 2006-01-01

  • PDF

• Outcome and late complications of radiotherapy in patients with unicentric Castleman disease

  Dirk Neuhof, Jürgen Debus

  1126-1131

  Published: 2006-01-01

  • PDF

• Radioactive iodine in thyroid medicine

  Torgny Rasmuson

  1011-1012

  Published: 2006-01-01

  • PDF

• Endocrine ophthalmopathy and radioiodine therapy

  F. Anders Karlsson

  1046-1050

  Published: 2006-01-01

  • PDF

• A patient surviving for eight years after proton and x-ray irradiation for advanced esophageal cancer

  Nobuyoshi Fukumitsu, Koichi Tokuuye, Shinji Sugahara, Takayuki Hashimoto, Masaharu Hata, Kiyoshi Ohara, Takeshi Shibahara, Akira Nakahara, Yasuyuki Akine

  1132-1134

  Published: 2006-01-01

  • PDF

• Radioiodine treatment for malignant thyroid disease

  Gertrud Berg

  1041-1045

  Published: 2006-01-01

  • PDF

• Thyroid cancer after exposure to radioactive 131I

  Lars-Erik Holm

  1037-1040

  Published: 2006-01-01

  • PDF

• Behavioral disorders secondary to profound hypomagnesemia in a patient given cetuximab for metastatic colorectal cancer hypomagnesemia due to cetuximab treatment

  Christophe Perrin, Cédric Fabre, Jean-Luc Raoul, Eveline Boucher

  1135-1136

  Published: 2006-01-01

  • PDF

• Radioactive iodine in thyroid medicine-How it started in Sweden and some of today's challenges

  Sören Mattsson, Lennart Johansson, Helene Jönsson, Bertil Nosslin

  1031-1036

  Published: 2006-01-01

  • PDF

• Re-treatment with cetuximab in patients with severe hypersensitivity reactions to cetuximab. Two case reports.

  Dorte L. Nielsen, Per Pfeiffer, Benny Vittrup Jensen

  1137-1138

  Published: 2006-01-01

  • PDF

• Present status of the use of recombinant human TSH in thyroid cancer management

  Markus Luster

  1018-1030

  Published: 2006-01-01

  • PDF

• BOOK REVIEW

  NIKLAS LOMAN

  1139

  Published: 2006-01-01

  • PDF

• Rectal cancer irradiation. Long course, short course or something else?

  Bengt Glimelius

  1013-1017

  Published: 2006-01-01

  • PDF

• BOOK REVIEW

  Hans Strander

  1140-1141

  Published: 2006-01-01

  • PDF